Did you know that your version of Internet Explorer is out of date?
To get the best possible experience using our website we recommend downloading one of the below web browsers.

Internet Explorer 9, Firefox, Chrome, or Safari.

Treatment Access News

Québec Demonstrates Leadership in the Treatment of HIV/AIDS by Providing Access to GENVOYA®

may 4, 2017

Gilead Sciences Canada, Inc. today recognizes Québec for including GENVOYA® tablets as a general benefit on the list of the Régie de l'assurance maladie du Québec (RAMQ), for the treatment of HIV-1 infection.

Read more